Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Features

Features
Allergic Rhinitis

31 May 05

Allergic rhinitis is an increasingly prevalent disorder, affecting up to 40% of children and up to 30% of adults in the UK. The disease has traditionally been considered as either seasonal or perennial depending on the allergenic triggers and their presence in the environment. Typically, tree pollen promotes seasonal symptoms between February and April, grass pollens in late May through to early August, whilst weed pollens and mould spores are common in late summer and early autumn.
CSF Medical Communications

Hepatitis A/Typhoid Fever

31 May 05

Although difficult to determine accurately, annual global figures for reported cases of hepatitis A and typhoid are estimated to be in the region of 1.5 million and at least 16 million, respectively. Moreover, typhoid fever accounts for up to 600,000 deaths worldwide each year. The two diseases are often found in partnership and have common routes of transmission, particularly where sanitation is poor.
CSF Medical Communications

Novel combinations breathe new life into COPD market

26 May 05

There are 31.2 million COPD sufferers in the US, Europe and Japan - a prevalence rate of approximately 4.4% of the general population. Thus, the development of novel dual-action, once-daily inhaled therapies will provide important new treatment options for COPD and play a major role in the expansion of the market over the next decade.
Datamonitor

Will once-daily Kaletra be enough to see off the threat of Reyataz?

20 May 05

In addition to the traditional clinical needs, such as efficacy and resistance profile, product characteristics such as dosing and side effects can be fundamental in maintaining market share in the maturing antiretroviral market. In response to the launch of two once-daily protease inhibitors (PI), Abbott has reformulated its leading PI drug, Kaletra (lopinavir/ritonavir) in a once-daily dose.
Datamonitor

Working iN Australia

18 May 05

A brief introduction with useful websites
Paula Mumby

Have you taken your Medication today? Y or N

18 May 05

With UK MP’s, Committees, Regulatory bodies, Health Services and Companies looking for someone to blame for the dangers of patient non-compliance and drug safety issues it’s time to learn how the simplest technology can deliver the biggest rewards and bring you closer to your patients.
Sarah Eadon

Latest antihormonals offer a new standard in breast cancer treatment

13 May 05

For decades, AstraZeneca's tamoxifen has been the standard therapy for hormone-receptor positive breast cancer patients post-surgery. Nearly two-thirds of early-stage breast cancer patients receive the drug post surgery. Now however newer antihormonal agents called aromatase inhibitors, which lower the estrogen level in the body are increasingly being used in place of tamoxifen.
Datamonitor

Cancer vaccines: a shot in the dark?

12 May 05

The idea of developing cancer vaccines is far from a novel concept. In fact initial attempts using tumor immunotherapy to combat cancer were made in the late 19th century by the American Dr William Coley. Unfortunately, despite Dr Coley's early efforts and those of numerous others since, there is still no effective therapeutic cancer vaccine on the market.
Datamonitor

NHS pharmaceutical messaging service

11 May 05

New on-line system for hospital pharmacies makes ordering medicines easier, quicker and, being paperless, virtually error-free.
Mike Wood

Reduce costs & increase efficiency with SMS

11 May 05

Did you know you can generate SMS messages from any software that can send an email or generate an HTTP request such as Outlook, Lotus Notes..?
Mike Wood

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.